Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation

Next Previous
Trial Profile

A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Jan 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Myocardial infarction; Stroke; Thromboembolism; Vascular disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms ACTIVE; ACTIVE-A
  • Sponsors Sanofi

    • Most Recent Events

    • 15 Nov 2021 Results investigating the association of NT-proBNP with heart rhythm and cardiovascular (CV) events in patients with AF without oral anticoagulation presented at the American Heart Association Scientific Sessions 2021
    • 04 Aug 2019 Results (n=962) of post-hoc analysis assessing thrombooembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment of this and ACTIVE-W trial published in the European Heart Journal
    • 05 Apr 2011 Combined results from this study and the AVERROES study presented at the 60th Annual Scientific Session of the American College of Cardiology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top